Sensei Biotherapeutics, Inc. (SNSE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 13.45M |
| Enterprise Value | 6.29M |
| P/E Ratio | -0.23 |
| PEG Ratio | 0 |
| Price/Sales Ratio | -170.05 |
| Price/Book Ratio | 1.04 |
| Enterprise/Revenue | -164.63 |
| Enterprise/EBITDA | -4.09 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 40.31 |
| Operating Margin | 40.99 |
| Return On Assets | -1.03 |
| Return On Equity | -1.93 |
| Revenue | 0 |
| Revenue/Share | -0.86 |
| Gross Profit | 0 |
| EBITDA | -20.91M |
| Net Income | -21.09M |
| Diluted EPS | -16.72 |
| Total Cash | 186.44M |
| Total Cash/Share | 33.04 |
| Total Debt | 592,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 19.69 |
| Book Value Per Share | 30.65 |
| 52-Week Change | 74.21 |
| 52-Week High | 36.76 |
| 52-Week Low | 6.33 |
| Moving Average 50 Days | 21.49 |
| Moving Average 200 Days | 16.71 |
| Average Volume | 52,333 |
| Shares Outstanding | 1.34M |
| % Held by Institutions | 194.39 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | June 17, 2025 |